This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Busulphan in CML

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Busulphan is a second line treatment for CML and is reserved for patients who are resistant to hydroxycarbamide (former British Approved Name, hydroxyurea)or are poorly compliant.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.